MedTrace Logo

Pulsed Low Dose Rate Radiation Therapy for Gastric Cancer Patients With Peritoneal Metastasis

NCT03061162 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2017-06-14

No results posted yet for this study

Summary

This phase II trial studies the side effects and response of pulsed low dose rate radiation therapy in treating gastric cancer patients with peritoneal metastasis.

Conditions

  • Radiotherapy
  • Radiotherapy Side Effect
  • Stomach Neoplasms

Interventions

RADIATION

pulsed low dose rate radiation therapy

Pulsed low dose rate 3-dimensional conformal radiation therapy

Sponsors & Collaborators

  • Yang Yang

    lead OTHER

Principal Investigators

  • Yang Yang, MD,PhD,MSCR · The Comprehensive Cancer Center of Nanjing Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-01
Primary Completion
2020-03-01
Completion
2022-03-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03061162 on ClinicalTrials.gov